Cox-1 Antibodies

Santa Cruz Biotechnology provides a broad selection of Cox-1 monoclonal antibodies for research applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cyclooxygenase-1 (Cox-1) is an enzyme responsible for converting arachidonic acid to prostaglandins, which mediate essential physiological functions such as platelet aggregation and gastric mucosal protection. Cox-1 research continues to reveal important insights about inflammation mechanisms, pain pathways, and cardiovascular disease development. Studying Cox-1 activity helps researchers understand its role in maintaining normal physiological functions. Cox-1 investigation is crucial for developing new therapeutic approaches for inflammatory conditions. Advanced research techniques allow scientists to examine Cox-1 expression patterns in different tissue types. Detailed analysis of Cox-1 pathways provides valuable information about cellular signaling networks. Understanding Cox-1 regulation mechanisms helps identify potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to conduct precise studies that advance scientific knowledge of Cox-1 biology and its impact on human health.